Company Analysis

Intelligent Bio Solutions Inc. (INBS)

Nasdaq: INBS · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2017
Grade3.5
◀ Past 2.4● Present 3.3▶ Future 5.1
1 est.

Who runs Intelligent Bio Solutions Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Boyages Steven Constantine
Interim CEO and Chairperson. First filing Dec 2020, latest Mar 20, 2026, 0 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
14 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Boyages Steven ConstantineInterim CEO and ChairpersonDec 2020Mar 20, 2026none
Simeonidis HarryChief Executive OfficerDec 2020Mar 20, 2026none
Sakiris Spiro KevinChief Financial OfficerDec 2020Mar 20, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fraser Nicola MariondirectorJun 2024Mar 20, 2026none
Hurd Jonathan ScottdirectorDec 2020Mar 20, 2026none
Isenberg JasondirectorOct 2022Mar 20, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton INBS · research, not advice